Retrospective Study
Copyright ©The Author(s) 2021.
World J Hepatol. Oct 27, 2021; 13(10): 1428-1438
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1428
Table 1 Clinical and laboratory characteristics in Wilson’s disease children with acute liver failure and hemolytic anemia
Parameter
All (n = 51)
ALF and hemolytic anemia(8 pts)
Other clinical forms(43 pts)
P value
Females, n (%)26 (50.98)8 (100)18 (41.86)0.00252
Mean age (yr)12.36 ± 3.7414.59 ± 2.2111.59 ± 3.790.03598
ALT (IU/L)131.54 ± 119.6987.38 ±154.07142.24 ± 110. 040.24969
AST (IU/L)125.05 ± 88.7378.62 ± 47.44136.30 ± 93.160.09950
TB (mg/dL)5.41 ± 12.9322.55 ± 21.950.99 ± 0.950.000002
DB (mg/dL)4.20 ± 11.5618.84 ± 20.400.42 ± 0.510.000007
GGT (IU/L)83.54 ± 43.4497.71 ± 57.1480.44 ± 40.330.34731
WBC (mm3)8568 ± 736014838 ± 141856666 ± 17990.00415
Hb (g/dL)12.15 ±2.967.4 ± 2.3913.51 ± 1.220.000000
PLT (mm3)253306 ±125421164875 ± 74043278571 ± 1264550.02142
INR2.94 ± 6.377.53 ± 11.341.18 ± 0.270.01359
KF ring, n (%) 9 (17.65)3 (37.50)6 (13.95)0.10868
Ceruloplasmin (mg/dL)9.81 ± 6.1187.98 ± 5.7710.11 ± 6.190.39976
Urinary copper (μg/24 h)648.94 ± 1093.902 236.33 ± 2 174.46384.38 ± 455.040.000006
Outcome, n (%)0.00121
Survivors47 (92.16)5 (62.50)42 (97.67)
Transplanted2 (3.92)2 (25.00)0
Deceased2 (3.92)1 (12.50)1 (2.33)